Collegium Pharmaceutical (COLL) News Today → War Over Taiwan? Protect Your Wealth NOW (From Behind the Markets) (Ad) Free COLL Stock Alerts $36.40 +0.56 (+1.56%) (As of 01:06 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Acquired by Federated Hermes Inc.marketbeat.com - April 26 at 5:31 AMCollegium to Report First Quarter 2024 Financial Results on May 9, 2024globenewswire.com - April 25 at 8:00 AMCollegium Pharmaceutical (NASDAQ:COLL) Upgraded to Strong-Buy at StockNews.comamericanbankingnews.com - April 24 at 4:18 AMCollegium Pharmaceutical (NASDAQ:COLL) Upgraded to "Strong-Buy" by StockNews.commarketbeat.com - April 23 at 11:12 PMCollegium Pharmaceutical Incmoney.usnews.com - April 23 at 10:29 AMOptimistic Buy Rating for Collegium Pharmaceutical: Growth and Market Position Analysismarkets.businessinsider.com - April 12 at 7:57 PMCritical Insights From Collegium Pharmaceutical Analyst Ratings: What You Need To Knowmarkets.businessinsider.com - April 11 at 2:00 PMCollegium Pharmaceutical (NASDAQ:COLL) Trading Down 3.9%marketbeat.com - April 11 at 1:48 PMCollegium Pharmaceutical's (COLL) Buy Rating Reiterated at Needham & Company LLCmarketbeat.com - April 11 at 8:26 AMCollegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026globenewswire.com - April 11 at 8:00 AMCollegium Pharmaceutical (COLL) Stock Sinks As Market Gains: What You Should Knowfinance.yahoo.com - April 9 at 11:27 PMPeregrine Capital Management LLC Decreases Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)marketbeat.com - April 9 at 3:30 PMNovan is gone. But its lead drug lives on with new companybizjournals.com - April 4 at 9:12 PMLigand Pharmaceuticals Announces Launch Of Pelthos; Scott Plesha To Assume Leadership Of Pelthosmarkets.businessinsider.com - April 3 at 2:04 PMCollegium to Participate in 23rd Annual Needham Virtual Healthcare Conferencefinance.yahoo.com - April 3 at 9:04 AMAssenagon Asset Management S.A. Sells 79,790 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)marketbeat.com - March 30 at 4:50 AMCollegium Pharmaceutical (NASDAQ:COLL) Hits New 1-Year High at $40.95marketbeat.com - March 28 at 10:52 AMPacer Advisors Inc. Purchases 883,380 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)marketbeat.com - March 25 at 8:24 AMCollegium Pharmaceutical Inc.wsj.com - March 23 at 6:25 AMCollegium Pharmaceutical (NASDAQ:COLL) Reaches New 1-Year High at $39.96marketbeat.com - March 22 at 1:44 PMCollegium Pharmaceutical (NASDAQ:COLL) Upgraded by StockNews.com to Strong-Buymarketbeat.com - March 21 at 11:15 PMCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Given Average Rating of "Moderate Buy" by Analystsmarketbeat.com - March 19 at 6:33 AMCollegium Pharmaceutical (NASDAQ:COLL) Sets New 1-Year High at $38.48marketbeat.com - March 15 at 12:38 PMBuy Rating Affirmed for KalVista Pharmaceuticals on Strong Phase 3 Results and Solid Financial Positionmarkets.businessinsider.com - March 11 at 9:53 PMQube Research & Technologies Ltd Acquires 111,394 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)marketbeat.com - March 10 at 5:21 AMTamarack Advisers LP Sells 190,000 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)marketbeat.com - March 8 at 5:27 PMCollegium Pharmaceutical (NASDAQ:COLL) Reaches New 52-Week High at $38.39marketbeat.com - March 8 at 1:24 PMRubric Capital Management LP Has $70.96 Million Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)marketbeat.com - March 6 at 6:45 AMCOLL Mar 2024 50.000 callfinance.yahoo.com - March 5 at 11:02 AM5 Best Small Cap Pharma Stocks to Invest Ininsidermonkey.com - March 4 at 11:21 PMCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Acquired by Trexquant Investment LPmarketbeat.com - March 1 at 6:48 AMInsider Sell: EVP & Chief Commercial Officer Scott Dreyer Sells 10,000 Shares of Collegium ...finance.yahoo.com - February 29 at 2:27 AMAnalysts Offer Insights on Healthcare Companies: Tarsus Pharmaceuticals (TARS), Protagonist Therapeutics (PTGX) and Viridian Therapeutics (VRDN)markets.businessinsider.com - February 28 at 4:25 PMThis Unsung Pharmaceutical Stock In The IBD 50 Hit A Buy Zone. Here's Why.finance.yahoo.com - February 27 at 2:15 PMCollegium Pharmaceutical Q4: The Beat Goes Onseekingalpha.com - February 26 at 2:35 PMCollegium Pharmaceutical (NASDAQ:COLL) Sets New 52-Week High After Analyst Upgrademarketbeat.com - February 26 at 9:29 AMTruist Financial Raises Collegium Pharmaceutical (NASDAQ:COLL) Price Target to $40.00marketbeat.com - February 26 at 8:24 AMCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Commonwealth of Pennsylvania Public School Empls Retrmt SYSmarketbeat.com - February 26 at 4:36 AMNasdaq Closes In On All-Time High; Carvana Spikes On Earnings While Nvidia Vaults Above 800msn.com - February 25 at 1:14 PMCollegium Pharmaceutical Full Year 2023 Earnings: EPS Beats Expectationsfinance.yahoo.com - February 24 at 10:48 AMStockNews.com Upgrades Collegium Pharmaceutical (NASDAQ:COLL) to Strong-Buymarketbeat.com - February 23 at 11:17 PMWhere Collegium Pharmaceutical Stands With Analystsmarkets.businessinsider.com - February 23 at 5:37 PMCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Consensus Rating of "Moderate Buy" from Analystsmarketbeat.com - February 23 at 3:54 PMCollegium Pharmaceutical (NASDAQ:COLL) Earns "Overweight" Rating from Piper Sandlermarketbeat.com - February 23 at 2:32 PMCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Q4 2023 Earnings Call Transcriptinsidermonkey.com - February 23 at 11:06 AMQ4 2023 Collegium Pharmaceutical Inc Earnings Callfinance.yahoo.com - February 23 at 7:37 AMRecap: Collegium Pharmaceutical Q4 Earningsbenzinga.com - February 22 at 9:36 PMCollegium Pharmaceutical Inc Reports Record Earnings for Q4 and Full-Year 2023finance.yahoo.com - February 22 at 9:36 PMCollegium Pharmaceutical, Inc. 2023 Q4 - Results - Earnings Call Presentationseekingalpha.com - February 22 at 8:23 PMCollegium Reports Record Fourth Quarter and Full-Year 2023 Financial Resultsglobenewswire.com - February 22 at 4:09 PM Get Collegium Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for COLL and its competitors with MarketBeat's FREE daily newsletter. Email Address War Over Taiwan? Protect Your Wealth NOW (Ad)With tensions rapidly escalating, Taiwan could provide the spark at any moment. Don't let your financial future get caught in the crossfire unprepared. Access my report now >>> COLL Media Mentions By Week COLL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. COLL News Sentiment▼0.000.33▲Average Medical News Sentiment COLL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. COLL Articles This Week▼53▲COLL Articles Average Week Get Collegium Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for COLL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GMTX News Today DCPH News Today ABCL News Today PIRS News Today MIRM News Today MNKD News Today XNCR News Today LGND News Today SYRE News Today PCRX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:COLL) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collegium Pharmaceutical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
